Back to Journals » Psoriasis: Targets and Therapy » Volume 6
![](https://www.dovepress.com/cr_data/cache/journal_image/121/cope/thumb_100_1000_100.jpg)
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (141)
- Volume 14, 2024 (8)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 6, 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
![](cr_data/cache/submission_images/s105000/105047/105047 figure 1 revised_200_200_90.jpg)
Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T
Psoriasis: Targets and Therapy 2016, 6:165-173
Published Date: 12 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tacrolimus for the management of psoriasis: clinical utility and place in therapy
Malecic N, Young H
Psoriasis: Targets and Therapy 2016, 6:153-163
Published Date: 7 December 2016
![Noteworthy comment: Herpes Zoster is one of the most common infectious diseases in patients receiving treatment by biologics. Everybody who cares for such patients should be familiar with the problem.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
el Hayderi L, Colson F, Dezfoulian B, Nikkels AF
Psoriasis: Targets and Therapy 2016, 6:145-151
Published Date: 18 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pustular psoriasis: pathophysiology and current treatment perspectives
![](cr_data/cache/submission_images/s98000/98954/10_aug_2016_figure_2_ppp_200_200_90.jpg)
Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B
Psoriasis: Targets and Therapy 2016, 6:131-144
Published Date: 12 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psoriasis in children
Pinson R, Sotoodian B, Fiorillo L
Psoriasis: Targets and Therapy 2016, 6:121-129
Published Date: 20 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
Svendsen MT, Andersen KE, Andersen F, Hansen J, Pottegård A, Johannessen H
Psoriasis: Targets and Therapy 2016, 6:113-119
Published Date: 23 August 2016
![Noteworthy comment: The real life treatment of psoriasis is a combination of different approaches. For evidence-based treatment this review is an important step.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J
Psoriasis: Targets and Therapy 2016, 6:105-111
Published Date: 28 July 2016
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/Imo2WwZhLlI/1.jpg)
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W
Psoriasis: Targets and Therapy 2016, 6:93-104
Published Date: 20 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psoriasis and inflammatory bowel disease: links and risks
Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID
Psoriasis: Targets and Therapy 2016, 6:73-92
Published Date: 20 July 2016
![Noteworthy comment: This paper demonstrates important links between smoking and worsening of psoriasis or reduced therapeutic response of the disease. It points to the fact that patients who are a smoker and are affected by psoriasis can positively influence the course of their disease by quitting smoking.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psoriasis and smoking: links and risks
Naldi L
Psoriasis: Targets and Therapy 2016, 6:65-71
Published Date: 27 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects
Franken SM, Vierstra CL, Rustemeyer T
Psoriasis: Targets and Therapy 2016, 6:55-64
Published Date: 18 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Assessment and monitoring of biologic drug adverse events in patients with psoriasis
Hanley T, Handford M, Lavery D, Yiu ZZN
Psoriasis: Targets and Therapy 2016, 6:41-54
Published Date: 1 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of scalp psoriasis: current perspectives
Blakely K, Gooderham M
Psoriasis: Targets and Therapy 2016, 6:33-40
Published Date: 29 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current knowledge on psoriasis and autoimmune diseases
![](cr_data/cache/submission_images/s64000/64950/figure 1_200_200_90.jpg)
Ayala-Fontánez N, Soler DC, McCormick TS
Psoriasis: Targets and Therapy 2016, 6:7-32
Published Date: 22 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
Landriscina A, Friedman AJ
Psoriasis: Targets and Therapy 2016, 6:1-5
Published Date: 19 January 2016